Skip to content

Neoadjuvant durvalumab plus chemotherapy in resectable or borderline resectable non-small-cell lung cancer: the phase 2 MDT-BRIDGE trial

Photo

Neoadjuvant durvalumab plus chemotherapy in resectable or borderline resectable non-small-cell lung cancer: the phase 2 MDT-BRIDGE trial — Neoadjuvant durvalumab with chemotherapy lets most lung cancer patients undergo surgery

Used in

Neoadjuvant durvalumab with chemotherapy lets most lung cancer patients undergo surgery en